← Holders
Sphera Funds Management Ltd.
What Sphera Funds Management Ltd. reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1496201 · Filed Nov 16, 2026
- Positions
- 113
- Reported value
- $707.5M
- Opened
- 32
- Closed
- 24
- Other managers included
- 2
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$474.1M114 positions
- Dec 31, 2025$517.3M99 positions
- Mar 31, 2026$629.7M96 positions
- Jun 30, 2026$766.5M105 positions
- Sep 30, 2026$707.5M113 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
MLYSMineralys Therapeutics, Inc. | 1.3M | −10.1% | $33.2M | 4.7% |
TEVATeva Pharmaceutical Industries Ltd | 821.3K | New | $32.5M | 4.6% |
ALNYAlnylam Pharmaceuticals, Inc. | 120.6K | +1,016.7% | $29.8M | 4.2% |
CYTKCytokinetics Inc | 361.9K | +64.5% | $23.9M | 3.4% |
ISHARES TRISHARES SEMICDTR | 37K | New | $21M | 3% |
BBIOBridgeBio Pharma, Inc. | 311.7K | +27.1% | $20.5M | 2.9% |
TSEMTower Semiconductor Ltd | 84.7K | −21.7% | $19.3M | 2.7% |
SNDXSyndax Pharmaceuticals Inc | 1M | −0.7% | $18.9M | 2.7% |
BMRNBioMarin Pharmaceutical Inc | 293.2K | −10.7% | $17.6M | 2.5% |
BIIBBiogen Inc. | 75.8K | −21.6% | $17.1M | 2.4% |
COGTCogent Biosciences, Inc. | 501.5K | +9.2% | $16.1M | 2.3% |
NVMINova Ltd. | 39K | +55.1% | $15M | 2.1% |
MDGLMadrigal Pharmaceuticals, Inc. | 25.8K | +48.1% | $13M | 1.8% |
SPDR SERIES TRUSTST STR SP BIOTPut option | 75K | −50.0% | $11.8M | 1.7% |
METAMeta Platforms, Inc. | 16.2K | New | $11.7M | 1.7% |
IMTXImmatics N.V. | 1.3M | +81.2% | $11.5M | 1.6% |
SNYSanofi | 269.5K | ±0% | $11.1M | 1.6% |
AZNAstraZeneca PLC | 68.5K | +9.6% | $11.1M | 1.6% |
ARK ETF TRGENOMIC REV ETFPut option | 200K | New | $10.8M | 1.5% |
MAZEMaze Therapeutics, Inc. | 366.3K | −12.3% | $10M | 1.4% |
LLYEli Lilly & Co | 8K | ±0% | $9.3M | 1.3% |
KLACKLA Corp | 45.2K | New | $8.8M | 1.2% |
LRCXLAM Research Corp | 25.9K | +40.2% | $8.5M | 1.2% |
PFEPfizer Inc | 286K | ±0% | $8.2M | 1.2% |
IDYAIDEAYA Biosciences, Inc. | 211.4K | +7.6% | $8.1M | 1.1% |
RYTMRhythm Pharmaceuticals, Inc. | 80.4K | ±0% | $7.7M | 1.1% |
JNJJohnson & Johnson | 28.8K | ±0% | $7.6M | 1.1% |
TNGXTango Therapeutics, Inc. | 304.3K | +19.7% | $7.6M | 1.1% |
IRONDisc Medicine, Inc. | 114.7K | +80.6% | $7.5M | 1.1% |
VORVor Biopharma Inc. | 383.4K | −7.9% | $7.3M | 1% |
AMATApplied Materials Inc | 14.3K | +29.5% | $7.3M | 1% |
ABVXAbivax S.A. | 73.7K | New | $7.3M | 1% |
PHVSPharvaris N.V. | 229.7K | New | $7.3M | 1% |
CAMTCamtek Ltd | 46.8K | New | $7.3M | 1% |
MRKMerck & Co., Inc. | 48.6K | −17.1% | $7.1M | 1% |
NVCTNuvectis Pharma, Inc. | 323.4K | −15.5% | $6.8M | 1% |
NVSNovartis AG | 45K | −10.0% | $6.4M | 0.9% |
ABBVAbbVie Inc. | 22.3K | −26.4% | $5.8M | 0.8% |
TRAXFirst Tracks Biotherapeutics, Inc. | 160.2K | +474.8% | $5.7M | 0.8% |
TRVITrevi Therapeutics, Inc. | 385.3K | −22.8% | $5.5M | 0.8% |
MSLESatellos Bioscience Inc. | 638.7K | −2.1% | $5.4M | 0.8% |
ANNXAnnexon, Inc. | 1.2M | New | $5.2M | 0.7% |
RAREUltragenyx Pharmaceutical Inc. | 338.6K | −42.5% | $5.1M | 0.7% |
CLYMClimb Bio, Inc. | 416.7K | −13.9% | $4.8M | 0.7% |
HELPHelus Pharma Inc. | 388.2K | −76.1% | $4.8M | 0.7% |
ORICOric Pharmaceuticals, Inc. | 349.4K | −53.6% | $4.7M | 0.7% |
RVMDRevolution Medicines, Inc. | 22.4K | ±0% | $4.6M | 0.6% |
NVONovo Nordisk a S | 120.7K | ±0% | $4.6M | 0.6% |
ELVNEnliven Therapeutics, Inc. | 99.8K | −11.5% | $4.6M | 0.6% |
TENXTenax Therapeutics, Inc. | 2.3M | +1,826.5% | $4.4M | 0.6% |
TECXTectonic Therapeutic, Inc. | 187.4K | New | $4.4M | 0.6% |
GSKGSK PLC | 90K | −11.8% | $4.3M | 0.6% |
RLAYRelay Therapeutics, Inc. | 233.8K | ±0% | $4.2M | 0.6% |
SVRASavara Inc | 802.6K | +6.1% | $4.1M | 0.6% |
CBIOCrescent Biopharma, Inc. | 279.7K | New | $4.1M | 0.6% |
ACADAcadia Pharmaceuticals Inc | 202.1K | −43.3% | $4.1M | 0.6% |
OVIDOvid Therapeutics Inc. | 1.6M | +18.3% | $4M | 0.6% |
ANLAdlai Nortye Group Ltd. | 235.7K | New | $3.8M | 0.5% |
MDWDMediWound Ltd. | 273.2K | ±0% | $3.8M | 0.5% |
HRMYHarmony Biosciences Holdings, Inc. | 95.8K | −45.8% | $3.8M | 0.5% |
ACOGAlpha Cognition Inc. | 415.6K | −23.9% | $3.7M | 0.5% |
QTTBQ32 Bio Inc. | 448.9K | New | $3.7M | 0.5% |
IMMXImmix Biopharma, Inc. | 355.8K | +31.8% | $3.7M | 0.5% |
| 300K | New | $3.7M | 0.5% | |
| 12.5K | ±0% | $3.6M | 0.5% | |
AVTXAvalo Therapeutics, Inc. | 235K | +1.2% | $3.6M | 0.5% |
DYNDyne Therapeutics, Inc. | 222.6K | +11.5% | $3.6M | 0.5% |
| 250K | New | $3.6M | 0.5% | |
ELDNEledon Pharmaceuticals, Inc. | 1.4M | +16.9% | $3.5M | 0.5% |
SRRKScholar Rock Holding Corp | 72.3K | −23.3% | $3.5M | 0.5% |
CRVSCorvus Pharmaceuticals, Inc. | 298.2K | +21.7% | $3.4M | 0.5% |
| 100K | New | $3.4M | 0.5% | |
RAPPRapport Therapeutics, Inc. | 100K | New | $3.4M | 0.5% |
PALIPalisade Bio, Inc. | 2.5M | +9.2% | $3.3M | 0.5% |
LRMRLarimar Therapeutics, Inc. | 1M | +11.8% | $3.3M | 0.5% |
PRLDPrelude Therapeutics Inc | 844.8K | −17.2% | $3.3M | 0.5% |
| 100K | New | $3.2M | 0.5% | |
EVMNEvommune, Inc. | 390.6K | +1,626.0% | $3.2M | 0.5% |
LTGOLatigo Biotherapeutics, Inc. | 192.1K | New | $3.2M | 0.5% |
AAOIApplied Optoelectronics, Inc. | 32.2K | New | $3.2M | 0.5% |
CTNMContineum Therapeutics, Inc. | 221.4K | +20.7% | $3M | 0.4% |
CLDXCelldex Therapeutics, Inc. | 91.1K | −62.2% | $3M | 0.4% |
PRQRProQR Therapeutics N.V. | 1.8M | ±0% | $2.9M | 0.4% |
KURAKura Oncology, Inc. | 267.5K | −9.3% | $2.9M | 0.4% |
WVEWave Life Sciences, Inc. | 747.3K | +17.1% | $2.8M | 0.4% |
PMNProMIS Neurosciences Inc. | 254.8K | −21.7% | $2.8M | 0.4% |
AMGNAmgen Inc | 6K | −20.0% | $2.5M | 0.4% |
CABACabaletta Bio, Inc. | 1.3M | −4.9% | $2.4M | 0.3% |
| 100K | New | $2.3M | 0.3% | |
BBOTBridgeBio Oncology Therapeutics, Inc. | 464.5K | +0.8% | $1.9M | 0.3% |
| 100K | New | $1.9M | 0.3% | |
UPBUpstream Bio, Inc. | 325.8K | +48.3% | $1.7M | 0.2% |
PYXSPyxis Oncology, Inc. | 689K | New | $1.6M | 0.2% |
ERASErasca, Inc. | 109.2K | New | $1.6M | 0.2% |
JBIOJade Biosciences, Inc. | 105.5K | New | $1.5M | 0.2% |
IKTInhibikase Therapeutics, Inc. | 688.3K | +6.0% | $1.4M | 0.2% |
BIOABioAge Labs, Inc. | 182.6K | −14.6% | $1.3M | 0.2% |
TSHATaysha Gene Therapies, Inc. | 250K | ±0% | $1.2M | 0.2% |
NTLAIntellia Therapeutics, Inc. | 90.3K | New | $1.1M | 0.2% |
QNRXQuoin Pharmaceuticals Ltd. | 236.2K | New | $1.1M | 0.2% |
| 250K | New | $1.1M | 0.1% | |
| 250K | New | $1.1M | 0.1% | |
SRZNSurrozen, Inc. | 18.8K | New | $605.7K | 0.1% |
HOWLWerewolf Therapeutics, Inc. | 626.8K | ±0% | $578.1K | 0.1% |
VYGRVoyager Therapeutics, Inc. | 214.6K | −49.8% | $575K | 0.1% |
ORGOOrganogenesis Holdings Inc. | 330K | −40.0% | $452.1K | 0.1% |
CTMXCytomX Therapeutics, Inc. | 125.4K | −85.7% | $341.1K | 0.1% |
| 50K | New | $334.5K | 0.1% | |
| 127.6K | ±0% | $241.2K | 0.1% | |
TRAWTraws Pharma, Inc. | 398.5K | ±0% | $236.6K | 0.1% |
APREAprea Therapeutics, Inc. | 270K | ±0% | $202.5K | 0.1% |
SKYESkye Bioscience, Inc. | 87.3K | −87.1% | $140.5K | 0.1% |
CRISCuris Inc | 39.7K | New | $33.3K | 0.1% |